ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,891Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 406

$526K Total Retail Price of All Prescriptions

Rank: 15 out of 406

699 Patients Receiving at Least One Drug in Part D
69% Patients 65 Years and Older
53% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New Hampshire
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

16% of this provider’s 699 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

8% of this provider’s 699 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
LISINOPRIL 343 253 66 1 1
OMEPRAZOLE 317 223 65 2 4
LEVOTHYROXINE SODIUM 303 252 51 3 3
FUROSEMIDE 273 247 48 4 7
AMLODIPINE BESYLATE 264 191 54 5 6
WARFARIN SODIUM 225 209 35 6 12
ATORVASTATIN CALCIUM 219 164 48 7 5
HYDROCHLOROTHIAZIDE 197 141 55 8 8
HYDROCODONE-ACETAMINOPHEN 187 96 46 S3 9 16
METOPROLOL TARTRATE 160 133 39 10 9
OXYCODONE HCL 155 70 32 S2 11 15
LOVASTATIN 148 112 39 12 30
SIMVASTATIN 147 120 52 13 2
METOPROLOL SUCCINATE 130 113 32 14 13
GABAPENTIN 114 87 33 15 17
CITALOPRAM HBR 112 70 27 16 19
ATENOLOL 112 107* 28 16 11
LORAZEPAM 107 69 36 B 18 20
SERTRALINE HCL 93 60 18 19 21
VENLAFAXINE HCL ER 90 60 20 20 62
CLONAZEPAM 86 50 25 B 21 25
LOSARTAN POTASSIUM 83 78* 22 22 18
LANTUS SOLOSTAR 76 47 15 23 78
METFORMIN HCL 72 54 22 24 10
RISPERIDONE 71 <11 <11 A 25 75
DONEPEZIL HCL 70 57 12 26 35
CARVEDILOL 70 65* 13 26 53
FLUTICASONE PROPIONATE 68 52 25 28 45
ESCITALOPRAM OXALATE 67 56 12 29 42
OXYCODONE HCL-ACETAMINOPHEN 66 <11 <11 S2 30 81
CLOPIDOGREL 65 46 15 31 32
POTASSIUM CHLORIDE 62 57* 17 32 26
TRAZODONE HCL 59 29 15 33 24
TAMSULOSIN HCL 59 <11 <11 33 34
PANTOPRAZOLE SODIUM 56 41 14 35 22
PREDNISONE 56 42 24 35 40
ZOLPIDEM TARTRATE 55 30 14 37 28
ALLOPURINOL 54 <11 <11 38 39
GLIPIZIDE ER 54 37 12 38 120
MORPHINE SULFATE ER 54 <11 <11 S2 38 68
OXYCODONE-ACETAMINOPHEN 53 30 28 S2 41 46
KLOR-CON M20 52 <11 <11 42 76
NEXIUM 52 47* 13 42 36
NAMENDA 52 <11 <11 42 29
POLYETHYLENE GLYCOL 3350 51 46* 12 45 57
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.